Antiviral Drugs Market Set to Witness an Uptick during 2020 to 2027



The global antiviral drugs market size is expected to reach USD 46.9 billion by 2027, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of -2.3% over the forecast period. Increasing geriatric population is considered to be the major factor anticipated to drive the demand for efficient treatment of human immunodeficiency virus (HIV) infections.
Antiviral drugs are in high demand due to the ongoing Covid-19 pandemic. However, due to the breakdown of the value chain in relevant APIs exported from China, there is a global shortage being observed. With manufacturers working hard to maintain positive credit, it is to be observed how antiviral drugs demand will be met. The estimates & forecast update will take into account the all-important impact of coronavirus.
According to the Centers of Disease Control and Prevention (CDC), nearly half the people diagnosed with HIV in U.S. are aged 50 and older. Furthermore, according to the data published in World Population Prospects: The 2020 Revision, one in six people globally is estimated to be over age of 65 years by 2050. In addition, one in four persons living in Northern America and Europe would be aged 65 years and above by 2050. The number of persons aged 80 years and above is estimated to triple, from 143 million in 2020 to 426 million in 2050. The increasing aging population worldwide would have a direct impact on the healthcare systems, who would have to meet the needs of the aging population. This, in turn, would drive the demand for antiviral drugs, which can be used to treat a range of viral infections.
Presence of pipeline antiviral products for HIV therapeutics is anticipated to drive the market over the forecast period. For instance, ViiV Healthcare is developing Cabotegravir/rilpivirine (long-acting injectable), which is currently under Phase III and are types of NNRTI/ INSTI drug class. In addition,GS-6207 (capsid inhibitor) and vesatolimod (TLR-7 agonist) are being developed by Gilead Sciences and are currently under Phase I trial for the treatment of HIV. Moreover, advancements in epidemiology and growing awareness of viral diseases are expected to result in a high demand for efficient treatment solutions.
According to the CDC, the prevalence of oral herpes (HSV-1) and genital herpes (HSV-2) was 47.8% and 11.9% respectively, from 2015 to 2016. The Herpes Resource Center (HRC) provides public awareness, education, and patient support. Moreover, the Hepatitis B Foundation provides information such as diagnosis, preventive measures, and treatment. Increasing preventive measures with the availability of various vaccines is expected to hinder the market growth over the forecast period.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/antiviral-drugs-market/request/rs1
The global antiviral drugs market size was valued at USD 56.4 billion in 2020 and is expected to register a CAGR of -2.3% over the forecast period. Antiviral drugs are used for the treatment of viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza. Broad-spectrum antiviral drugs can be used to treat a range of viruses. Moreover, several investigational drugs for the treatment of HIV infection are currently in the pipeline. Increasing instances of HIV infections are estimated to drive the demand for antiviral drugs.
Increasing prevalence of viral infections such as HIV, hepatitis, respiratory syncytial virus (RSV), and influenza is expected to drive the demand for antiviral drugs. For instance, according to data published by the WHO, hepatitis B caused around 887,000 deaths in 2015. Moreover, it was estimated that around 257 million patients were living with hepatitis B virus (HBV) infection in 2015. This is expected to drive the demand for efficient treatment solutions such as antiviral drugs.
Further key findings from the report suggest:
·         Reverse transcriptase inhibitors held the largest share in 2020 and is estimated to be the fastest-growing segment over the forecast period as these inhibitors slow down or prevent viral replication
·         DNA polymerase inhibitors was the second-largest segment in 2020 owing to its effectiveness in combating drug resistance
·         Generic products are estimated to be the fastest-growing segment over the forecast period owing to increased adoption of generic drugs in developing countries
·         Hepatitis dominated the application segment in 2020 owing to the availability of various antiviral products for its treatment
·         HIV is estimated to be the fastest-growing segment over the forecast period due to its increasing prevalence and incidence rate
·         North America dominated the global antiviral drugs market in 2020 owing to the presence of key players in the region and the availability of a well-established healthcare infrastructure.
Based on drug class, the market is classified into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others. Reverse transcriptase inhibitors held the largest share in 2020 and is estimated to be the fastest-growing segment over the forecast period as they are effective in slowing down or preventing viral infection. Reverse transcriptase inhibitors include nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). Drugs used in the treatment of HIV include Zidovudine, Stavudine, Zalcitabine, Efavirenz, Nevirapine, Etravirine, and Didanosine.
Browse Press Release of this report:
https://www.grandviewresearch.com/press-release/global-antiviral-drugs-market
Grand View Research has segmented the global antiviral drugs market on the basis of drug class, type, application:
Antiviral Drug Class Outlook (Revenue, USD Billion, 2016 - 2027)
·         DNA Polymerase Inhibitors
·         Reverse Transcriptase Inhibitors
·         Protease Inhibitors
·         Neuraminidase Inhibitors
·         Others
Antiviral Drugs Type Outlook (Revenue, USD Billion, 2016 - 2027)
·         Branded
·         Generics
Antiviral Drugs Application Outlook (Revenue, USD Billion, 2016 - 2027)
·         HIV
·         Hepatitis
·         Herpes
·         Influenza
·         Others
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.



Comments

Post a Comment

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

Image
The global foot orthotic insoles market size is expected to reach USD 5.5 billion by 2026 , according to a new report by Grand View Research, Inc., exhibiting a 6.3% CAGR during the forecast period. Growing incidence of diabetes and plantar fasciitis are expected to drive the market over the forecast period. Moreover, rapid urbanization and increasing disposable income are anticipated to propel growth in future. Technological advancements, spurred by ongoing investments in R&D, are expected to increase growth potential in the coming years. Moreover, rise in geriatric population, which is susceptible to orthopedic disorders, is impelling product demand globally. For instance, in 2017 as per the U.S. Census Bureau, the number of people aged 65 or older increased by 1.6 million from 2014 to 2015. In addition, increasing incidence of sports injuries and rising prevalence of osteosarcoma in the region has led to the need for various orthotics devices, which is expected to drive ...
Read more

A Look into Smokehouse Industry……Deep Analysis…..

Image
The global smokehouse market size is anticipated to reach USD 157.2 million by 2025 , according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 2.2% during the forecast period. Rising need for a healthy lifestyle has led consumers to prefer griller or barbequed food over fried food and other kinds of fast food. This trend is expected to have a positive impact on the market growth. The home care & decor industry has been witnessing inconsistent growth, since the Covid 19 outbreak. As a result of the ongoing pandemic crisis, there has been a drop in the overall performance of discretionary products such as decorative fixtures, bedding products, to name a few. The virus outbreak has, however, led to substantial growth in categories such as cleaning and hygiene products. Prominent growth in the e-commerce business is also one of the positive influences of the outbreak, wherein companies are focusing on expanding their distribution ...
Read more

A Look into Shapewear Industry……Deep Analysis…..

Image
The global shapewear market size is expected to reach USD 3.80 billion by 2025 registering a CAGR of 7.7%, according to a new report by Grand View Research, Inc. The introduction of various products according to the type of garments is expected to support the market growth in the years to come. Growing target population across the globe is also augmenting the market growth. Changing lifestyle incurs increased investment in fitness and related accessories, which has positively impacted the market growth. The clothing, footwear, & accessories industry is anticipated to witness checkered growth throughout 2020, as a result of the unprecedented supply chain disruptions caused by the COVID-19 outbreak worldwide. The expected decline in the global sales of clothing, footwear, & accessories is attributable to massive supply chain disruptions across significant export markets, including China and India. However, the industry is likely to recover over the forecast timeframe,...
Read more